Work with thought leaders and academic experts in Pharmaceutical Science

Companies can greatly benefit from working with experts in the field of Pharmaceutical Science. These researchers bring a wealth of knowledge and experience that can contribute to various aspects of a company's operations. Here are some ways companies can collaborate with academic researchers in Pharmaceutical Science: 1. Research and Development: Academic researchers can provide valuable insights and expertise in developing new drugs, formulations, and delivery systems. They can contribute to the discovery of novel compounds, conduct preclinical and clinical trials, and optimize drug efficacy and safety. 2. Innovation and Technology Transfer: Pharmaceutical Science researchers can help companies stay at the forefront of innovation by transferring cutting-edge technologies and research findings. They can assist in the development of new drug delivery methods, formulation techniques, and manufacturing processes. 3. Regulatory Compliance: Academic researchers are well-versed in regulatory requirements and can assist companies in navigating complex regulatory frameworks. They can provide guidance on compliance with FDA regulations, quality control, and safety standards. 4. Collaboration on Grants and Funding: Academic researchers often have access to funding opportunities and can collaborate with companies on grant applications. They can help companies secure research grants and funding for collaborative projects. 5. Education and Training: Pharmaceutical Science researchers can provide training and education to company employees. They can conduct workshops, seminars, and training programs to enhance the knowledge and skills of the company's workforce.

Researchers on NotedSource with backgrounds in Pharmaceutical Science include Keisha Walters, Elvira Forte, Joel T. Nadler, Aimee Eggler, Professor(Dr) Sanjay Rout, Katie Barr, Maurice O'Sullivan, Yuan Yang, VIJAYASSHEKAR MANUKONDA, Giuseppe Maria de Peppo, Ratshilumela Steve Dima, Kamal Al-Malah, Ph.D., Morgan Edwards, Jessica D. Hess, Ph.D., and Thaddeus Allen.

Keisha Walters

Fayetteville, Arkansas, United States of America
27 Years Experience
University of Arkansas
Education

Clemson University

PhD, Chemical Engineering / 2005

Clemson, South Carolina, United States of America

Clemson University

BS, Biological Sciences / 1996

Clemson, South Carolina, United States of America

Clemson University

M.S., Chemical Engineering / May, 2001

Clemson, South Carolina, United States of America
Experience

University of Arkansas College of Engineering

Endowed Chair and Professor of Chemical Engineering / August, 2021 — Present

University of Oklahoma

Professor of Chemical, Biological and Materials Engineering / 2016 — 2021

Developing a world-class research program in stimuli reponsive polymers and polymer-grafted nanoparticles for biomedical, energy, and environmental applications. Committed to balance and excellence in research scholarship, teaching scholarship, and service to the profession. Passionate about instilling a love of learning and curiosity about how the world works physically in future generations.

Mississippi State University

Professor of Engineering / 2005 — 2016

Professor of Chemical Engineering who is committed to research, teaching, and service. My research is focused on polymer and nanoparticle-based material design, including ‘smart’ stimuli responsive polymers, polymer-nanoparticle constructs for biomedical and energy applications, and bio-based products such as polymers and fuels.

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (34)
Materials Chemistry
Inorganic Chemistry
Polymers and Plastics
Organic Chemistry
Fluid Flow and Transfer Processes
And 29 more
About
Her research covers a broad range of topics in polymer- and nano-based materials engineering and transport modeling, which has been published in 110+ refereed technical manuscripts and presented at numerous national and international conferences. Dr. Walters’ work has been sponsored by government agencies including NSF, DOE, and DOD, and by industry partners.
Most Relevant Publications (2+)

102 total publications

Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect

Pharmaceutics / Apr 17, 2021

Frickenstein, A. N., Hagood, J. M., Britten, C. N., Abbott, B. S., McNally, M. W., Vopat, C. A., Patterson, E. G., MacCuaig, W. M., Jain, A., Walters, K. B., & McNally, L. R. (2021). Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics, 13(4), 570. https://doi.org/10.3390/pharmaceutics13040570

Bioluminescent magnetic nanoparticles as potential imaging agents for mammalian spermatozoa

Journal of Nanobiotechnology / Mar 17, 2016

Vasquez, E. S., Feugang, J. M., Willard, S. T., Ryan, P. L., & Walters, K. B. (2016). Bioluminescent magnetic nanoparticles as potential imaging agents for mammalian spermatozoa. Journal of Nanobiotechnology, 14(1). https://doi.org/10.1186/s12951-016-0168-y

See Full Profile

Elvira Forte

New York, New York, United States of America
15 Years Experience
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education

Sapienza University of Rome

PhD, Pasteurian Sciences / January, 2011

Rome

Sapienza University of Rome

Master, Medical, Molecular and Cellular Biotechnology / October, 2006

Rome

Sapienza University of Rome

Bachelor, Biotechnology / October, 2004

Rome
Experience

Springer Nature

Associate/Senior Editor / June, 2021 — February, 2024

Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.

Research Fellow/Associate Research Scientist / January, 2017 — June, 2021

• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.

Post-doctoral fellow/ Co-joint lecturer / May, 2013 — November, 2016

Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales

Scientific Editor / March, 2024 — Present

Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (26)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 21 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.
Most Relevant Publications (1+)

63 total publications

A Chemical Biology Approach to Myocardial Regeneration

Journal of Cardiovascular Translational Research / Mar 22, 2011

Willems, E., Lanier, M., Forte, E., Lo, F., Cashman, J., & Mercola, M. (2011). A Chemical Biology Approach to Myocardial Regeneration. Journal of Cardiovascular Translational Research, 4(3), 340–350. https://doi.org/10.1007/s12265-011-9270-6

See Full Profile

Joel T. Nadler

Bloomfield , Indiana, United States of America
14 Years Experience
Former Professor of Psychology, SIUE: Senior Consultant PDRI
Education

Southern Illinois University Carbondale

Ph.D., Applied (Industrial / Organizational) Psychology / August, 2010

Carbondale, Illinois, United States of America
Experience

Southern Illinois University Edwardsville

Professor: Director I/O Masters Program / August, 2010 — August, 2022

AON Assessment Solutions

Senior Consultant / July, 2022 — March, 2024

PDRI

Senior Consultant / April, 2024 — Present

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (18)
Industrial Organizational Psychology
Gender Studies
Social Psychology
Business and International Management
Strategy and Management
And 13 more
About
Joel T. Nadler is Senior Consultant at PDRI and an adjunct faculty member at the University of Indiana. He was a formerly at Aon Assessment Solutions and a Professor of I/O psychology at SIUE. Dr. Nadler has taught classes including Industrial/Organizational Psychology, Personnel Psychology, Organizational Development, Employee Selection, Test and Measures, graduate and undergraduate Research Design and Statistics, Social Psychology, Group Dynamics, Organizational Behavior, and Psychology of Gender. ​ Dr. Nadler has in the past actively worked as an independent consultant and as a co-founder of AOA Consulting and has consulted with organizations on areas such as assessment validation, organizational climate and culture, survey development, performance appraisal, program evaluation, needs assessment, organizational change and development, and study design and methodology. Dr. Nadler research interests include gender bias in selection and performance appraisal, sexual harassment, organizational attractiveness, adverse impact (EEO law), and assessing inclusive diversity practices.  Additionally, Dr. Nadler has expertise in advanced measurement, design and statistical techniques. His research has been published in journals such as Industrial Organizational Psychology: *Perspectives on Science and Practice, Sex Roles, Social Issues and Policy Review,  Journal of Applied Social Psychology, American Journal of Evaluation, Journal of Leadership and Organizational Studies.*   Dr. Nadler enjoys cycling, traveling, horseback riding, motorcycling, music, science fiction, and collecting bourbon and scotch when he is not busy consulting and conducting research.
Most Relevant Publications (2+)

47 total publications

Sex Differences in Delaying Family: Effects on Job and Life Satisfaction

Journal of Psychology Research / Jun 28, 2011

Joshua Doerner, Joel T. Nadler, & Meghan R. Lowery. (2011). Sex Differences in Delaying Family: Effects on Job and Life Satisfaction. Journal of Psychology Research, 1(6). https://doi.org/10.17265/2159-5542/2011.06.006

Research Report: Implicit and Explicit Measures of Sexism Predicting Men’s Interviewing Behaviors

Journal of Organizational Psychology / Dec 30, 2020

Research Report: Implicit and Explicit Measures of Sexism Predicting Men’s Interviewing Behaviors. (2020). Journal of Organizational Psychology, 20(5). https://doi.org/10.33423/jop.v20i5.3693

See Full Profile

Aimee Eggler

Villanova, Pennsylvania, United States of America
20 Years Experience
Professor of Chemistry and Biochemistry at Villanova University
Education

University of California, Santa Cruz

BS, Chemistry / May, 1996

Santa Cruz, California, United States of America

University of Wisconsin–Madison

Ph.D., Biochemistry / May, 2002

Madison, Wisconsin, United States of America
Experience

Villanova University

Associate Professor of Chemistry / 2019 — Present

Villanova University

Assistant Professor / 2012 — 2019

Purdue University

Research Assistant Professor / 2010 — 2012

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (18)
Biochemistry
Physiology (medical)
Toxicology
Organic Chemistry
Clinical Biochemistry
And 13 more
About
Dr. Eggler has 20 years of experience in the field of redox biology, with a focus on the Nrf2 transcription factor, a master regulator of antioxidant, detoxification and anti-inflammatory genes. She is also an award-winning educator and the recipient of the Villanova University Junior Faculty Excellence in Teaching award. Her interests in education include innovation in teaching metabolism from a logic-based perspective.
Most Relevant Publications (2+)

25 total publications

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

Bioorganic &amp; Medicinal Chemistry Letters / Nov 01, 2013

Turlington, M., Chun, A., Tomar, S., Eggler, A., Grum-Tokars, V., Jacobs, J., Daniels, J. S., Dawson, E., Saldanha, A., Chase, P., Baez-Santos, Y. M., Lindsley, C. W., Hodder, P., Mesecar, A. D., & Stauffer, S. R. (2013). Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. Bioorganic &amp; Medicinal Chemistry Letters, 23(22), 6172–6177. https://doi.org/10.1016/j.bmcl.2013.08.112

Insecticidal Activity of Cyanohydrin and Monoterpenoid Compounds

Molecules / Apr 03, 2000

Peterson, C., Tsao, R., Eggler, A., & Coats, J. (2000). Insecticidal Activity of Cyanohydrin and Monoterpenoid Compounds. Molecules, 5(12), 648–654. https://doi.org/10.3390/50400648

See Full Profile

Professor(Dr) Sanjay Rout

Delhi
18 Years Experience
Industry Expert Dr. Sanjay - Former Honorary Chancellor, Leading Chair Professor and Advisory Consultant for Research and Development Forums.
Education

The Wharton Business School

Business Analytics

Philadelphia

Magadh University

Ph.D, Management / March, 2017

Gaya

Institute of management technology

PGDSCM, Management / October, 2009

Delhi
Experience

Mahavideha University

Chancellor / June, 2021 — March, 2023

Innovation Solution Lab

CEO / October, 2019 — May, 2021

Spiritual Data

Board of Directors / July, 2023 — Present

Board of directors

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (14)
HealthScience
Technology
Management
Law
Journalism
And 9 more
About
Dr. Sanjay Rout is an experienced professor and business professional with a diverse educational background. He holds a Ph.D in Management from Magadh University, as well as a PGDSCM in Management from the Institute of management technology. In addition, he has also completed a LLB in Law and an MBA in Management. Dr. Rout's expertise lies in the field of Business Analytics, which he studied at The Wharton Business School. He has also gained valuable experience through his various roles in the business world, including serving as the Chancellor at Mahavideha University, CEO at Innovation Solution Lab, and COO at ISL PUBLICATIONS. Dr. Rout is also involved in various organizations and serves on the Board of Directors at Spiritual Data. He has also worked as a consultant for companies such as NISG, Ernst and Young LLP, Pwc and Sutra PMU, and CAEMAS. With his extensive education and experience, Dr. Sanjay Rout is a highly knowledgeable and respected professor in the field of Business Analytics.
Most Relevant Publications (1+)

32 total publications

Some Current Publications

Restoration: Studies in English Literary Culture, 1660-1700 / Jan 01, 2013

Smith, M. (2013). Some Current Publications. Restoration: Studies in English Literary Culture, 1660-1700, 37(2), 91–100. https://doi.org/10.1353/rst.2013.0019

See Full Profile

Katie Barr

Warrington
8 Years Experience
Bioinformatician and developer with strong academic and commercial experience
Education

University of Leeds

Ph.D, Quantum Information / December, 2013

Leeds

University of Manchester

MSc, Mathematical logic and the theory of computation / December, 2009

Manchester

University of Bristol

BSc, Physics and Philosophy with study in Continental Europe / July, 2008

Bristol
Experience

Earlham Institute

Scientific programmer / November, 2015 — July, 2018

Genome assembly algorithm development

University of Manchester

Post doc bioinformatician in Nanomedicine group / June, 2019 — October, 2020

Wise range of bioinformatics tasks, mostly in RNASeq and Proteomics

Kromek

Associate Principal Scientist- Bioinformatics / November, 2020 — Present

Environmental metagenomics pipeline development for pathogen detection

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (11)
Computer Science Applications
Atomic and Molecular Physics, and Optics
Bioengineering
Pharmacology (medical)
Biochemistry (medical)
And 6 more
About
Katie Barr is a bioinformatician with a strong background in computer science. She received her Ph.D in Quantum Information from the University of Leeds in 2013. She also holds an MSc in Mathematical logic and the theory of computation from the University of Manchester, and a BSc in Physics and Philosophy with study in Continental Europe from the University of Bristol. Katie has extensive experience working in the fields of bioinformatics and software development. She has worked as a scientific programmer at the Earlham Institute, a postdoctoral bioinformatician in the Nanomedicine group at the University of Manchester, and is now an Associate Principal Scientist in Bioinformatics at Kromek. Katie is passionate about using her knowledge and skills to improve the lives of others and she is dedicated to the advancement of science and technology. She believes in the power of collaboration and works to create meaningful partnerships between industry and academia.
Most Relevant Publications (2+)

9 total publications

Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model

Advanced Therapeutics / Oct 09, 2020

de Lázaro, I., Sharp, P., Gurcan, C., Ceylan, A., Stylianou, M., Kisby, T., Chen, Y., Vranic, S., Barr, K., Taheri, H., Ozen, A., Bussy, C., Yilmazer, A., & Kostarelos, K. (2020). Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model. Advanced Therapeutics, 4(1). Portico. https://doi.org/10.1002/adtp.202000109

Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models

Advanced Healthcare Materials / Nov 11, 2022

Sharp, P. S., Stylianou, M., Arellano, L. M., Neves, J. C., Gravagnuolo, A. M., Dodd, A., Barr, K., Lozano, N., Kisby, T., & Kostarelos, K. (2022). Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models. Advanced Healthcare Materials, 12(3). Portico. https://doi.org/10.1002/adhm.202201968

See Full Profile

Maurice O'Sullivan

Cork
29 Years Experience
University College Cork, School of Food and Nutritional Sciences
Education

Sensory and Consumer Science / March, 2002

Copenhagen
Experience

Univsersity College Cork

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (33)
sensory
meat
dairy
consumer
Food Science
And 28 more
About
Dr. Maurice O’ Sullivan is a sensory scientist and senior lecturer in food science working in the School of Food and Nutritional Sciences, UCC. In the past Maurice has worked in the food industry as a sensory scientist and flavour chemist for Diageo Baileys and Guinness. He has worked as a food technologist and process/product development scientist for the processed foods sector in the 1990’s as well as more recently a product development consultant to the dairy, meat and beverage industries. He has a Ph.D. in Sensory and Consumer science from the Department of Food Science, University of Copenhagen, Denmark as well as MSc. and BSc. Degrees in Food Science and Technology from University College Cork (UCC). Currently Maurice works in the School of Food and Nutritional Sciences, University College Cork as a senior lecturer and sensory and product reformulation project coordinator on large scale multi-million euro research projects. For many years he has also managed the “Sensory Unit” at UCC working on sensory and flavour based projects involving a diverse selection of products. This sensory science based service (at UCC) includes testing the difference, affective and descriptive analysis of foods and beverages as well as assessing shelf-life and comparing sensory results to microbiological and analytical (instrumental, physic-chemical) data using multivariate data analysis (MVA). Sensory testing is critical for new product development/optimisation, ingredient substitution and devising appropriate packaging and comparing foods or beverages to competitor’s products. Again, the key to unlocking the hidden secrets of this multimodal data is with MVA (Multivariate Data Analysis). To date Maurice has secured significant research funding of €5,300,000 Gross, €3,843,329.30 to UCC. He has worked in the area of targeted ingredient (salt, fat, sugar) reduction in foods since 1997. The focus of this research has been reduction of negative ingredients linked to civilisation diseases (Diabetes, Obesity, Heart Disease, Anaemia) while maintaining sensory properties, but also improving nutritional quality of developed products. To date this research has produced numerous publications with many more in development. Other research areas include Cross Cultural Sensory Perception of Irish Dairy Products in Asia, Europe and North America as well as Foods for the Elderly, Packaging and Meat optimisation. Maurice has published more than 200 sensory or consumer research based articles (papers, book chapters, proceedings etc.).
Most Relevant Publications (1+)

85 total publications

Dietary Compounds Influencing the Sensorial, Volatile and Phytochemical Properties of Bovine Milk

Molecules / Dec 19, 2019

Clarke, H. J., Griffin, C., Rai, D. K., O’Callaghan, T. F., O’Sullivan, M. G., Kerry, J. P., & Kilcawley, K. N. (2019). Dietary Compounds Influencing the Sensorial, Volatile and Phytochemical Properties of Bovine Milk. Molecules, 25(1), 26. https://doi.org/10.3390/molecules25010026

See Full Profile

Yuan Yang

10 Years Experience
Assistant Professor at Columbia University
Education

Stanford University

PhD, Materials Science and Engineering / June, 2012

Stanford, California, United States of America

Peking University

B.S., Physics / July, 2007

Beijing
Experience

Columbia University

Assistant Professor / July, 2012 — Present

Massachusetts Institute of Technology

Postdoc / July, 2012 — June, 2015

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (32)
Colloid and Surface Chemistry
Biochemistry
Catalysis
Materials Chemistry
Electrochemistry
And 27 more
About
Yuan Yang is an Assistant Professor of Materials Science and Engineering at Columbia University. He received his Ph.D. in Materials Science and Engineering from Stanford University in 2012. His research interests include nanomaterials and optoelectronic devices. He has published over 50 papers in peer-reviewed journals and has been awarded several patents.
Most Relevant Publications (2+)

142 total publications

Characterization of Water Self-Diffusion in Human Stratum Corneum

Journal of Pharmaceutical Sciences / Apr 01, 2018

Kodiweera, C., Yang, Y., & Bunge, A. L. (2018). Characterization of Water Self-Diffusion in Human Stratum Corneum. Journal of Pharmaceutical Sciences, 107(4), 1131–1142. https://doi.org/10.1016/j.xphs.2017.12.011

Characterization of Water and a Model Lipophilic Compound in Human Stratum Corneum by NMR Spectroscopy and Equilibrium Sorption

Journal of Pharmaceutical Sciences / Nov 01, 2016

Kodiweera, C., Romonchuk, W. J., Yang, Y., & Bunge, A. L. (2016). Characterization of Water and a Model Lipophilic Compound in Human Stratum Corneum by NMR Spectroscopy and Equilibrium Sorption. Journal of Pharmaceutical Sciences, 105(11), 3376–3386. https://doi.org/10.1016/j.xphs.2016.08.010

See Full Profile

VIJAYASSHEKAR MANUKONDA

Biotechnologist with core competence in biochemistry/cell-biology/molecular biology
Education

Jawaharlal Nehru Technological University, Hyderabad

BIOTECHNOLOGY / February, 2014

Hyderabad
Experience

UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (15)
Alzheimer
Type I and Type II Diabetes
Cancer
Neurobiology
Structural Biology
And 10 more
About
At UNC, I worked on type 1 diabetes, particularly the regulatory role of AIM2, a DNA sensor inflammasome molecule associated with autoimmune disorders. NOD mice deficient in AIM2 do not develop diabetes, indicating a potential beyond host defense. My research involves mapping AIM2's functional binding partners using various methods. During my time at FIU, I worked on characterizing glycan structures in ovarian cancer and developing a peptide and glycan array for identifying potential biomarkers. At BIIR in Dallas, I researched nuclear hormonal transcription factors implicated in autoimmune disorders and cancers, utilizing various methods. Additionally, my work at UTMB in Galveston involved studying cell adhesion molecules linked to neurological disorders, using biochemical and biophysical techniques. My academic background includes extensive knowledge of molecular and biochemical techniques gained at Jawaharlal Nehru Technological University in Hyderabad, India.
Most Relevant Publications (2+)

15 total publications

Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors

Bioorganic &amp; Medicinal Chemistry Letters / May 01, 2013

Chandrasekharappa, A. P., Badiger, S. E., Dubey, P. K., Panigrahi, S. K., & Manukonda, S. R. V. V. V. (2013). Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors. Bioorganic &amp; Medicinal Chemistry Letters, 23(9), 2579–2584. https://doi.org/10.1016/j.bmcl.2013.02.109

Design and Synthesis of Novel 2- Substituted Benzothiazole Compounds as PTP1B Inhibitors

Letters in Drug Design &amp; Discovery / Mar 31, 2014

Chandrasekharappa, A., Badiger, S., Dubey, P., Panigrahi, S., & Manukonda, S. (2014). Design and Synthesis of Novel 2- Substituted Benzothiazole Compounds as PTP1B Inhibitors. Letters in Drug Design &amp; Discovery, 11(4), 444–453. https://doi.org/10.2174/15701808113106660076

See Full Profile

Giuseppe Maria de Peppo

Brooklyn, New York, United States of America
15 Years Experience
Research Director
Education

Ph.D, Stem Cells and Tissue Engineering / May, 2011

Gotebörg

Politecnico di Milano

Master of Science, Material Science / February, 2006

Milan

Università degli Studi di Roma "La Sapienza"

Bachelor of Science, Biotechnology / September, 2003

Rome
Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (21)
Clinical Biochemistry
Cell Biology
Endocrinology
Otorhinolaryngology
Biochemistry
And 16 more
About
I am Director of Internal Research at Mirimus Inc, Research Assistant Professor of Cell Biology at SUNY, and Visiting Scholar at NYU Tandon School of Engineering. The major goal of my research team is to develop next generation sensing devices for the detection and monitoring of different human health hazards. Previous research directions include the engineering of tissue grafts and tissue replacement products, the manufacturing and testing of implants and biomaterials, the design and validation of bioreactor systems, organ-on-a-chip, and stem cell-based therapy. During over 15 years of research, I have had the opportunity to teach and mentor numerous undergraduate and graduate students and supervise several PhD and postdoctoral fellows.
Most Relevant Publications (2+)

33 total publications

Osteogenic response of human mesenchymal stem cells to well-defined nanoscale topography in vitro

International Journal of Nanomedicine / May 01, 2014

de Peppo, G. M., Agheli, H., Karlsson, C., Ekstrom, K., Brisby, H., Lenneras, M., Gustafsson, S., Sjövall, P., Johansson, A., Olsson, E., Lausmaa, J., Thomsen, P., & Petronis, S. (2014). Osteogenic response of human mesenchymal stem cells to well-defined nanoscale topography in vitro. International Journal of Nanomedicine, 2499. https://doi.org/10.2147/ijn.s58805

A Polymer Canvas with the Stiffness of the Bone Matrix to Study and Control Mesenchymal Stem Cell Response

Advanced Healthcare Materials / Jan 13, 2023

Zanut, A., Li, R., Deng, R., Liu, X., Rejhon, M., Chen, W., Weck, M., de Peppo, G. M., & Riedo, E. (2023). A Polymer Canvas with the Stiffness of the Bone Matrix to Study and Control Mesenchymal Stem Cell Response. Advanced Healthcare Materials, 12(10). Portico. https://doi.org/10.1002/adhm.202201503

See Full Profile

Ratshilumela Steve Dima

7 Years Experience
CSIR
Education

University of Venda

PHD PHYSICS, PHYSICS

Thohoyandou

University of Venda

MSC PHYSICS, PHYSICS / December, 2017

Thohoyandou

University of Venda

BSC HONOURS (PHYSICS), PHYSICS / December, 2015

Thohoyandou
Experience

Council for Scientific and Industrial Research, South Africa

Senior Researcher / February, 2021 — Present

Council for Scientific and Industrial Research

PHD Fellow / February, 2019 — Present

University of Venda

Part-Time Physics Lecture / March, 2018 — January, 2019

DST-NRF Research Intern / April, 2017 — February, 2018

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (19)
Multiscale modelling and simulations
Mathematical Physics
Condensed Matter Physics
Atomic and Molecular Physics, and Optics
Electrochemistry
And 14 more
About
I am a highly accomplished senior researcher with a Master of Science (MSc) degree in physics and a proven track record in multiple interdisciplinary fields. My expertise spans across modeling and simulation, renewable energy, data science, DevOps, and project management. With over 7 years of experience, I have successfully contributed to numerous projects, publications, and innovations, making a significant impact in each domain. My diverse skill set, commitment to excellence, and leadership abilities make me a valuable asset to any organization seeking innovative solutions and research leadership.
Most Relevant Publications (1+)

13 total publications

Phase Separation of Br-Doped CsPbI3: A Combined Cluster Expansion, Monte Carlo, and DFT Study

Molecules / Dec 22, 2023

Maleka, P., Dima, R., Tshwane, D., Ntwaeaborwa, O., & Maphanga, R. (2023). Phase Separation of Br-Doped CsPbI3: A Combined Cluster Expansion, Monte Carlo, and DFT Study. Molecules, 29(1), 92. https://doi.org/10.3390/molecules29010092

See Full Profile

Kamal Al-Malah, Ph.D.

31 Years Experience
Aspen Plus and MATLAB Expert as Related to Modeling, Simulation, Design, and Economics of Chemical Processes
Education

Oregon State University

Ph.D., Chemical Engineering / September, 1993

Corvallis, Oregon, United States of America

Oregon State University

M.S., Chemical Engineering / March, 1991

Corvallis, Oregon, United States of America

Yarmouk University

B.S., Chemical Engineering / January, 1987

Irbid
Experience

Higher Colleges of Technology

Faculty Member / August, 2015 — December, 2021

King Faisal University

Faculty Member / September, 2014 — June, 2015

University of Hail

Dept. Head/Faculty Member / September, 2009 — June, 2014

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (35)
Chemical Engineering
MATLAB
ASPEN
Analytical Chemistry
Filtration and Separation
And 30 more
About
Dr. Kamal I.M. Al-Malah, a portable, platform-independent professor of chemical engineering. He holds B.S., M.S., and Ph.D. degrees all in chemical/biochemical engineering. Dr. Al-Malah graduated from Oregon State University in 1993, and his area of specialty during M.S. and Ph.D. programs dealt with protein interactions and behavior at interfaces in biological systems. He currently researches in the modeling, simulation, and optimization aspects of physical/biophysical systems and characterization of molecular properties within the dome of chemical, biochemical, pharmaceutical, and food engineering. Dr. Al-Malah is a sole book author with renowned publishers as shown below: 1. Al-Malah, K., “Machine and Deep Learning Using MATLAB Algorithms and Tools for Scientists and Engineers”, 1st Edition. Wiley & Sons, Inc. In Press (December, 2023). https://www.barnesandnoble.com/w/machine-and-deep-learning-using-matlab-kamal-i-m-al-malah/1143272911 https://www.amazon.com/Machine-Deep-Learning-Using-MATLAB/dp/1394209088/ 2\. Al\-Malah\, K\.\, “Aspen Plus: Chemical Engineering Applications”\, 2nd Edition\. Wiley & Sons\, Inc\. October\, 2022\. https://www\.wiley\.com/en\-ae/Aspen\+Plus:\+Chemical\+Engineering\+Applications\,\+2nd\+Edition\-p\-9781119868699 3\. Al\-Malah\, K\.\, “Aspen Plus: Chemical Engineering Applications”\, Wiley & Sons\, Inc\. \(http://eu\.wiley\.com/WileyCDA/WileyTitle/productCd\-1119131235\.html\) 4\. Al\-Malah\, K\.\, “MATLAB®: Numerical Methods with Chemical Engineering Applications”\, McGraw Hill\, Inc\.\, https://www\.accessengineeringlibrary\.com/content/book/9780071831284 https://www.amazon.com/author/al-malah
Most Relevant Publications (1+)

41 total publications

OPTIMIZATION OF DRUG SOLUBILITY USING ASPEN PLUS: ACETYLSALICYLIC ACID (ASPIRIN) SOLUBILITY – A SECOND CASE STUDY

Asian Journal of Pharmaceutical and Clinical Research / Mar 17, 2020

AL-MALAH, K. I. (2020). OPTIMIZATION OF DRUG SOLUBILITY USING ASPEN PLUS: ACETYLSALICYLIC ACID (ASPIRIN) SOLUBILITY – A SECOND CASE STUDY. Asian Journal of Pharmaceutical and Clinical Research, 178–184. https://doi.org/10.22159/ajpcr.2020.v13i4.37143

See Full Profile

Morgan Edwards

6 Years Experience
Assistant Professor at University of Wisconsin--Madison and Director of the Climate Action Lab
Education

Massachusetts Institute of Technology

Data, Systems, and Society / June, 2017

Cambridge, Massachusetts, United States of America

Massachusetts Institute of Technology

S.M., Technology and Policy / June, 2013

Cambridge, Massachusetts, United States of America

University of North Carolina at Chapel Hill

B.S., Environmental Science and Economics / December, 2010

Chapel Hill, North Carolina, United States of America
Experience

University of Wisconsin--Madison

Assistant Professor / August, 2020 — Present

University of Maryland

President's Postdoctoral Fellow / July, 2018 — June, 2020

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (16)
Climate Policy
Energy Systems
Industrial Ecology
Electronic, Optical and Magnetic Materials
Renewable Energy, Sustainability and the Environment
And 11 more
About
Morgan Edwards is an Assistant Professor at the La Follette School of Public Affairs at the University of Wisconsin--Madison and affiliated faculty with the Nelson Institute Center for Sustainability and the Global Environment, Energy Analysis and Policy Program, Holtz Center for Science and Technology Studies, Institute for Research on Poverty, and Data Science Institute. Her research focuses on modeling the role of technology in addressing the threat of climate change and assessing policies to accelerate equitable energy transitions. Her current projects include modeling the role of climate-tech in meeting net zero targets, evaluating the equity impacts of building electrification policies, and assessing pathways to transition natural gas infrastructure. She holds a PhD in Data, Systems, and Society from the Massachusetts Institute of Technology (MIT), a SM in Technology and Policy from MIT, and a BS in Environmental Science and Economics from the University of North Carolina at Chapel Hill. Prior to coming to Madison, she was a President’s Postdoctoral Fellow at the Center for Global Sustainability at the University of Maryland.
Most Relevant Publications (1+)

17 total publications

Satellite Data Applications for Sustainable Energy Transitions

Frontiers in Sustainability / Oct 03, 2022

Edwards, M. R., Holloway, T., Pierce, R. B., Blank, L., Broddle, M., Choi, E., Duncan, B. N., Esparza, Á., Falchetta, G., Fritz, M., Gibbs, H. K., Hundt, H., Lark, T., Leibrand, A., Liu, F., Madsen, B., Maslak, T., Pandey, B., Seto, K. C., & Stackhouse, P. W. (2022). Satellite Data Applications for Sustainable Energy Transitions. Frontiers in Sustainability, 3. https://doi.org/10.3389/frsus.2022.910924

See Full Profile

Jessica D. Hess, Ph.D.

7 Years Experience
T32 Postdoctoral Fellow at City of Hope Beckman Research Institute
Education

The University of Texas at El Paso

Graduate Certificate (Technical and Professional Writing) / March, 2023

El Paso, Texas, United States of America

The University of Texas at El Paso Department of Biological Sciences

Ph.D., Biological Sciences / December, 2022

El Paso, Texas, United States of America

Virginia Commonwealth University

B.S., Chemistry / May, 2015

Richmond, Virginia, United States of America
Experience

City of Hope Beckman Research Institute

T32 Postdoctoral Fellow / January, 2023 — Present

The University of Texas at El Paso

Graduate Research & Teaching Assistant / August, 2017 — December, 2022

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (12)
Drug Discovery
DNA Replication
DNA Repair
DNA Damage Response
Cancer Biology
And 7 more
About
Dr. Jessica D. Hess holds a Ph.D. in Biological Sciences from The University of Texas at El Paso (UTEP) and a B.S. in Chemistry from Virginia Commonwealth University. She completed a Graduate Certificate in Technical and Professional Writing from UTEP in 2023. Dr. Hess has extensive experience in the field of biological sciences, with a focus on cancer research. She has worked as a T32 Postdoctoral Fellow at the City of Hope Beckman Research Institute and as a Graduate Research & Teaching Assistant at UTEP. Her research has been published in several scientific journals, and she has presented her work at numerous conferences. In addition to her research experience, Dr. Hess is also passionate about science communication and technical writing. She has served as a writing tutor for undergraduate and graduate students and has taught courses on scientific writing and communication. Her expertise in both science and writing makes her a valuable asset to any team or project. Outside of her academic and professional pursuits, Dr. Hess enjoys hiking, cooking, and spending time with her family and pets. She is dedicated to promoting diversity and inclusion in STEM fields and is actively involved in outreach programs and mentoring opportunities for underrepresented students.
Most Relevant Publications (1+)

11 total publications

Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells

European Journal of Pharmaceutical Sciences / Nov 01, 2020

Tilekar, K., Upadhyay, N., Schweipert, M., Hess, J. D., Macias, L. H., Mrowka, P., Meyer-Almes, F.-J., Aguilera, R. J., Iancu, C. V., Choe, J., & Ramaa, C. S. (2020). Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells. European Journal of Pharmaceutical Sciences, 154, 105512. https://doi.org/10.1016/j.ejps.2020.105512

See Full Profile

Thaddeus Allen

San Francisco Bay Area, California, United States of America
20 Years Experience
Professional who facilitates science, strategy and team building in biotech with a knack for deconstructing complexity to provide insight and direction.
Education

University of Toronto

PhD, Department of Medical Biophysics - Molecular and Cellular Biology of Cancer / April, 2004

Toronto, Ontario, Canada

University of Toronto

MSc, Department of Medical Biophysics - Molecular and Cellular Biology of Cancer / October, 1998

Toronto, Ontario, Canada

BSc, Biology/Pharmacology Co-op Program / May, 1995

Hamilton, Ontario, Canada
Experience

The One Health Company

Scientific Writing Consultant / February, 2024 — Present

Science-based writing projects - The One Health Company offers next-generation sequencing screening of the canine cancer genome, coupled with matching targeted therapeutics.

Oncology Lead / August, 2018 — February, 2020

Product development, science consulting and writing projects related to PR, publications, legal and regulatory.

Tradewind BioScience, Inc.

CEO / January, 2018 — June, 2023

Startup that built an antibody for ovarian cancer treatment.

Anticancer Bioscience, Ltd.

VP Translational Biology and Business Development / August, 2018 — October, 2023

Hybrid position - responsible for both the mentoring of scientific teams researching small molecule drugs (MOA, PK, in vivo, etc.) and worked on strategic business development projects. Notably, the outward face of the company for partnering, vendor interactions and as a legal liaison.

Most Relevant Research Expertise
Pharmaceutical Science
Other Research Expertise (24)
cancer
fibrosis
therapeutics
diagnostics
Cell Biology
And 19 more
About
I am able to lead on various aspects of biotech including ideation and drug development, internal and CRO research, patent, partnership and KOL management, public relations and marketing and science writing projects.
Most Relevant Publications (3+)

50 total publications

In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis

Journal of Pharmaceutical and Biomedical Analysis / Aug 01, 2023

Li, J., Choudhry, N., Lv, G., Nimishetti, N., Reddy, M. C., Liu, H., Allen, T. D., Zhang, J., & Yang, D. (2023). In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis. Journal of Pharmaceutical and Biomedical Analysis, 232, 115415. https://doi.org/10.1016/j.jpba.2023.115415

Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B

Bioorganic &amp; Medicinal Chemistry / Feb 01, 2023

Lv, G., Shi, Q., Zhang, T., Li, J., Long, Y., Zhang, W., Choudhry, N., Yang, K., Li, H., Kalashova, J., Yang, C., Zhou, X., Reddy, M. C., Anantoju, K. K., Zhang, S., Zhang, J., Allen, T. D., Liu, H., Nimishetti, N., & Yang, D. (2023). Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B. Bioorganic &amp; Medicinal Chemistry, 80, 117173. https://doi.org/10.1016/j.bmc.2023.117173

The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects

Journal of Natural Products / Aug 18, 2021

Li, J., Yan, Z., Li, H., Shi, Q., Ahire, V., Zhang, S., Nimishetti, N., Yang, D., Allen, T. D., & Zhang, J. (2021). The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects. Journal of Natural Products, 84(8), 2312–2320. https://doi.org/10.1021/acs.jnatprod.1c00429

See Full Profile

Example Pharmaceutical Science projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Pharmaceutical Science?

Development of Novel Drug Delivery System

An academic researcher in Pharmaceutical Science can collaborate with a company to develop a novel drug delivery system. This project can involve the design and optimization of drug carriers, such as nanoparticles or liposomes, to improve drug stability, targeting, and release. The researcher can contribute expertise in formulation development, characterization techniques, and in vitro/in vivo evaluation.

Evaluation of Drug Efficacy and Safety

A company can collaborate with a Pharmaceutical Science researcher to evaluate the efficacy and safety of their drug candidates. The researcher can design and conduct preclinical and clinical trials, analyze the data, and provide insights on drug efficacy, dosage optimization, and potential side effects. This collaboration can help the company make informed decisions regarding drug development and regulatory submissions.

Optimization of Manufacturing Processes

Pharmaceutical Science researchers can collaborate with companies to optimize their manufacturing processes. They can analyze the existing manufacturing methods, identify areas for improvement, and propose strategies to enhance efficiency, reduce costs, and ensure product quality. This collaboration can lead to streamlined production processes and improved manufacturing outcomes.

Development of Personalized Medicine

Academic researchers in Pharmaceutical Science can collaborate with companies to develop personalized medicine approaches. They can contribute expertise in pharmacogenomics, biomarker identification, and drug response prediction. This collaboration can lead to the development of tailored treatment strategies, improved patient outcomes, and enhanced therapeutic efficacy.

Drug Formulation Optimization

A company can benefit from collaborating with a Pharmaceutical Science researcher to optimize their drug formulations. The researcher can analyze the physicochemical properties of the drug, evaluate different formulation approaches, and optimize drug solubility, stability, and bioavailability. This collaboration can result in improved drug formulations with enhanced therapeutic performance.